Alps Advisors Inc Cerevel Therapeutics Holdings, Inc. Transaction History

Alps Advisors Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$40.88 - $43.27 $1.24 Million - $1.31 Million	30,379 Added 31.1%	128,068 $5.41 Million
Q4 2023 Feb 14, 2024	SELL	$20.27 - $42.44 $376,494 - $788,280	-18,574 Reduced 15.98%	97,689 $4.14 Million
Q3 2023 Nov 14, 2023	BUY	$20.26 - $31.91 $19,935 - $31,399	984 Added 0.85%	116,263 $2.54 Million
Q2 2023 Aug 14, 2023	BUY	$23.9 - $35.38 $288,449 - $427,001	12,069 Added 11.69%	115,279 $3.66 Million
Q1 2023 May 10, 2023	SELL	$22.82 - $35.32 $65,173 - $100,873	-2,856 Reduced 2.69%	103,210 $2.52 Million
Q4 2022 Feb 14, 2023	BUY	$25.35 - $31.96 $534,783 - $674,228	21,096 Added 24.83%	106,066 $3.35 Million
Q3 2022 Nov 14, 2022	SELL	$25.5 - $41.42 $76,474 - $124,218	-2,999 Reduced 3.41%	84,970 $2.4 Million
Q2 2022 Aug 11, 2022	SELL	$20.62 - $37.15 $1.32 Million - $2.38 Million	-64,146 Reduced 42.17%	87,969 $2.33 Million
Q1 2022 May 16, 2022	SELL	$23.5 - $35.38 $429,674 - $646,887	-18,284 Reduced 10.73%	152,115 $5.33 Million
Q4 2021 Feb 09, 2022	SELL	$29.21 - $44.64 $209,318 - $319,890	-7,166 Reduced 4.04%	170,399 $5.52 Million
Q3 2021 Nov 15, 2021	BUY	$21.26 - $38.85 $224,973 - $411,110	10,582 Added 6.34%	177,565 $5.24 Million
Q2 2021 Aug 11, 2021	BUY	$12.56 - $29.69 $2.1 Million - $4.96 Million	166,983 New	166,983 $4.28 Million

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.